Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» DNL747
DNL747
After Disappointing Study Results, Denali and Sanofi Shift Resources to a Different Alzheimer's Drug
BioSpace
Thu, 06/11/20 - 10:49 pm
Denali Therapeutics
Sanofi
DNL747
ALS
Alzheimer's disease
DNL788
clinical trials
Denali scoots past a setback with barely a scratch, quickly calling up a backup Alzheimer’s player on the bench
Endpoints
Wed, 06/10/20 - 11:00 am
Denali Therapeutics
Genentech
DNL747
Denali Therapeutics starts testing novel approach to fight Alzheimer’s
GoinPharma
Wed, 03/21/18 - 09:16 am
Denali Therapeutics
Alzheimer's disease
DNL747
Teva Pharmaceutical